According to the latest research report, the medical devices market size was worth USD 9877.4 million in 2019 and is expected to grow at a CAGR of 23.20 percent to USD 63423.6 million by 2027.

The primary aldosteronism market size is projected to grow by 8.40%. Aldosteronism is a hormone in the human body. The adrenal glands regulate sodium and potassium in the blood through this hormone.

Transgenic animals carry a foreign gene deliberately inserted into its genome. The insertion of the foreign DNA into the host body is carried out by the application of recombinant DNA technology.

Malabsorption Syndrome Market is expected to grow at a CAGR of 11.0% during the forecast period of 2017-2023.

Nephroblastoma knew as Wilms’ Tumor is a rare type of malignant kidney cancer generally found in children mostly under the age of seven.

The Electronic Health Record (EHR) is a longitudinal electronic record of patient health information including medication, past medical history, complications, patient demographics, progress notes, immunizations, vital signs, laboratory data and others.

Market Research Future (MRFR) has published a report recently which asserts that the global digital wound measurement devices market share is prognosticated to expand at a moderate CAGR over the review period 2018 to 2023.

It is estimated that the costochondritis market is expected to register an increasing CAGR during the forecast period from 2018 to 2023.

The global vitamin testing market is expected to witness tremendous growth during the forecast period at a CAGR of ~9.2%. There are 13 types of different vitamins namely Vitamin A, vitamin B (thiamine, riboflavin, niacin, pantothenic acid, biotin, vitamin...

As per the market report, the Pain Management Market Size is estimated to rise upon to enlist a CAGR of 4.50% during the estimated time of 2020–2027. And the market may arrive at USD 85,300 million by 2027.

The market valuation of the healthcare cold chain logistics market by the year 2023 is predicted to be 16,588.3 million. The compound annual growth rate or CAGR of the market during the assessment period from 2108 to 2023 is estimated to reach around 7.54...

It is estimated that the cell harvesting market is expected to register a CAGR of Approx. 12.60% with an estimated market value of USD 9.8 Billion during the forecast period from 2020 to 2027.

The keloid treatment market is expected to reach USD 3.9 billion by 2023 and is expected to increase at a CAGR of 3.5 % during the forecast period from 2018 to 2023.

The apoptosis assays market is expected to grow significantly over the forecast period. The market held a value of USD 2.99 billion in 2017 and is projected to register a CAGR of 9.4% over the forecast period.

As per the market analysis by MRFR, the high potency APIs market will rake USD 26.6 billion in revenues while expanding with an 8.40% CAGR in the forecast period.